Literature DB >> 22267623

Is quadruple therapy the new triple therapy for H pylori?

Christina Korownyk1, Michael R Kolber.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22267623      PMCID: PMC3264013     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Helicobacter pylori treatment in the era of increasing antibiotic resistance.

Authors:  David Y Graham; Lori Fischbach
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

3.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

4.  Empiric therapies for Helicobacter pylori infections.

Authors:  David Y Graham; Lori A Fischbach
Journal:  CMAJ       Date:  2011-02-22       Impact factor: 8.262

Review 5.  Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada.

Authors:  C A Fallone
Journal:  Can J Gastroenterol       Date:  2000-11       Impact factor: 3.522

6.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.

Authors:  Dino Vaira; Angelo Zullo; Nimish Vakil; Luigi Gatta; Chiara Ricci; Federico Perna; Cesare Hassan; Veronica Bernabucci; Andrea Tampieri; Sergio Morini
Journal:  Ann Intern Med       Date:  2007-04-17       Impact factor: 25.391

Review 7.  Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection.

Authors:  Richard Hunt; Carlo Fallone; Sander Veldhuyzan van Zanten; Phil Sherman; Fiona Smaill; Nigel Flook; Alan Thomson
Journal:  Can J Gastroenterol       Date:  2004-09       Impact factor: 3.522

Review 8.  Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.

Authors:  Jay Luther; Peter D R Higgins; Phillip S Schoenfeld; Paul Moayyedi; Nimish Vakil; William D Chey
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

9.  Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.

Authors:  Lorenzo Fuccio; Maria Eugenia Minardi; Rocco Maurizio Zagari; Diego Grilli; Nicola Magrini; Franco Bazzoli
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

10.  American College of Gastroenterology guideline on the management of Helicobacter pylori infection.

Authors:  William D Chey; Benjamin C Y Wong
Journal:  Am J Gastroenterol       Date:  2007-06-29       Impact factor: 10.864

View more
  1 in total

1.  N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial.

Authors:  Mohammad Hassan Emami; Mehdi Zobeiri; Hojatolah Rahimi; Fariba Arjomandi; Hamed Daghagzadeh; Peyman Adibi; Jalal Hashemi
Journal:  Adv Biomed Res       Date:  2014-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.